This notion is given further credence by the reports of altered plasma levels of CNP/NT-proCNP in human patients with cirrhosis, that correlate with disease severity (24–27) and increased CNP mRNA expression in experimental models of carbon tetrachloride (CCl4)-driven hepatic fibrosis (28). The gene discussed is CNP; the disease is Cirrhosis.